Market Value43,789,879
Total Holdings24
File Date2025-05-09
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ALNY / Alnylam Pharmaceuticals, Inc. Put
INBS / Intelligent Bio Solutions Inc.
RZLT / Rezolute, Inc.
LRMR / Larimar Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
SVRA / Savara Inc.
MMSI / Merit Medical Systems, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
ATEC / Alphatec Holdings, Inc.
BHVN / Biohaven Ltd.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ITCI / Intra-Cellular Therapies, Inc.
CLRB / Cellectar Biosciences, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
SRPT / Sarepta Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
APLT / Applied Therapeutics, Inc. Put
INSM / Insmed Incorporated
CAPR / Capricor Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
RMD / ResMed Inc.
LXEO / Lexeo Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
GKOS / Glaukos Corporation
ANAB / AnaptysBio, Inc.
ESTA / Establishment Labs Holdings Inc.
VERU / Veru Inc.
RXST / RxSight, Inc.
KPTI / Karyopharm Therapeutics Inc.
EXAS / Exact Sciences Corporation
ESTA / Establishment Labs Holdings Inc. Call
PRQR / ProQR Therapeutics N.V.
UNCY / Unicycive Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
IBRX / ImmunityBio, Inc.
TERN / Terns Pharmaceuticals, Inc.
SRRK / Scholar Rock Holding Corporation Call
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ORIC / ORIC Pharmaceuticals, Inc.
LUNG / Pulmonx Corporation
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
CTMX / CytomX Therapeutics, Inc.
ANAB / AnaptysBio, Inc. Put
KROS / Keros Therapeutics, Inc.
OKUR / OnKure Therapeutics, Inc.
ADMA / ADMA Biologics, Inc.
NKTR / Nektar Therapeutics
SBFM / Sunshine Biopharma, Inc.
LRMR / Larimar Therapeutics, Inc. Call
LGMK / LogicMark, Inc.
AVDL / Avadel Pharmaceuticals plc
PMN / ProMIS Neurosciences, Inc.
XENE / Xenon Pharmaceuticals Inc. Call
PROF / Profound Medical Corp.
EPIX / ESSA Pharma Inc.
ZVRA / Zevra Therapeutics, Inc.
AVR / Anteris Technologies Global Corp.
NVNO / enVVeno Medical Corporation
BTTR / SRx Health Solutions Inc.
EOLS / Evolus, Inc.
XTNT / Xtant Medical Holdings, Inc.
ACOG / Alpha Cognition Inc.
CTNM / Contineum Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
STSS / Sharps Technology, Inc.
KPTI / Karyopharm Therapeutics Inc.
CATX / Perspective Therapeutics, Inc.
SKYE / Skye Bioscience, Inc.
RVMD / Revolution Medicines, Inc.
VKTX / Viking Therapeutics, Inc.